Earlier today, the Food and Drug Administration (FDA) released a draft guidance that seeks to limit youth access to some flavored e-cigarettes and cigars. This announcement comes the same day the American Heart Association released a Presidential...
Rita RedbergFDA Restrictions Don’t Go Far Enough to Address the E-Cigarette Epidemic | American Heart Association
High-tech surgical robots aren’t an improvement over traditional operations, the F.D.A. warns. For some patients, the robots may be worse.
Rita RedbergSeems to me we should know if a device is safe and effective before FDA approval and before using in patients. Cancer Patients Are Getting Robotic Surgery. There’s No Evidence It’s Better.
A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.
Rita Redberg“patient advocacy” group take industry funding, and runs 6 figure ad campaign to oppose allowing Medicare drug plans to negotiate on drug pricing, calling it an “access” issue. Big Pharma Gave $ To Pt Advocacy Groups Opposing Medicare Changes khn.org/OTIyNTQw via @khnews
Elected officials have made a lot of noise about the cost of prescription drugs. Now they must demand answers from pharmaceutical companies.
Rita RedbergTime for action to lower unconscionably high drug pricing in US. Humira alone has applied for 247 patents! Pricing is way out of line from value and R&D costs. It’s Time for Pharmaceutical Companies to Have Their Tobacco Moment via @NYTimes
This Viewpoint discusses the forces underlying the explosion of biomarker measurement, the way the measures will likely be manipulated by market forces, and the harms that can result from overscreening and overdiagnosis, and proposes approaches to...
Their test is FDA approved, but that doesn’t necessarily mean it’s useful.
Rita RedbergCautionary tale of yet another example that FDA approval does not mean any clinical benefits. And definite risks - anxiety, more (unnecessary) tests and misdiagnosis.Why You Should Be Careful About 23andMe’s Health Test via @NYTimes
It's time for the relevant committees to tackle the regulation and prices of expensive and potentially dangerous medical devices, which are being inserted every day in thousands of patients in America's hospitals.